Magazine Article | December 3, 2018

Biopharma Supply Chains At Industry 4.0

Source: Life Science Leader

By Louis Garguilo, Chief Editor, Outsourced Pharma

One day you’ll select your CDMO based more on its communication and AI capabilities than on the humans who work there. Once selected, your machines and systems will connect directly to those at your partner’s, interact directly with your ERP (enterprise resource planning)-approved needs, and bypass the human interaction needed today to manage drug supply chains.

No, that day may not occur in 2019, but the next 12 months will continue to build a bridge to that future. Already, advanced machines designed and implemented for serialization reside at service providers to relay information to systems at drug sponsors. Biopharma companies have built “smart” facilities. Blockchain technologies for supply chain integration and management are being laid out. Still, to get to a full digital dialogue, drug sponsors and CDMOs alike will need to muster their resources and usher in what the rest of the world already calls Industry 4.0.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: